Inhibitory action of ICI-182,780, an estrogen receptor antagonist, on BK(Ca) channel activity in cultured endothelial cells of human coronary artery

Biochem Pharmacol. 2003 Nov 15;66(10):2053-63. doi: 10.1016/s0006-2952(03)00584-7.

Abstract

ICI-182,780 is known to be a selective inhibitor of the intracellular estrogen receptors. The effect of ICI-182,780 on ion currents was studied in cultured endothelial cells of human coronary artery. In whole-cell current recordings, ICI-182,780 reversibly decreased the amplitude of K(+) outward currents. The decrease in outward current caused by ICI-182,780 could be counteracted by further application of magnolol or nordihydroguaiaretic acid, yet not by 17beta-estradiol. Under current-clamp condition, ICI-182,780 (3microM) depolarized the membrane potentials of the cells, and magnolol (10 microM) or nordihydroguaiaretic acid (10 microM) reversed ICI-182,780-induced depolarization. In inside-out patches, ICI-182,780 added to the bath did not alter single-channel conductance of large-conductance Ca(2+)-activated K(+) channels (BK(Ca) channels), but decreased their open probability. ICI-182,780 reduced channel activity in a concentration-dependent manner with an IC(50) value of 3 microM. After BK(Ca) channel activity was suppressed by 2-methoxyestradiol (3 microM), subsequent application of ICI-182,780 (3 microM) did not further reduce the channel activity. The application of ICI-182,780 shifted the activation curve of BK(Ca) channels to positive potentials. Its decrease in the open probability primarily involved a reduction in channel open duration. ICI-182,780 also suppressed the proliferation of these endothelial cells with an IC(50) value of 2 microM. However, in coronary smooth muscle cells, a bell-shaped concentration-response curve for the ICI-182,780 effect on BK(Ca) channel activity was observed. This study provides evidence that ICI-182,780 can inhibit BK(Ca) channels in vascular endothelial cells in a mechanism unlikely to be linked to its anti-estrogen activity. The inhibitory effects on these channels may partly contribute to the underlying mechanisms by which ICI-182,780 affects endothelial function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Methoxyestradiol
  • Biphenyl Compounds / pharmacology
  • Cell Division / drug effects
  • Cells, Cultured
  • Coronary Vessels / cytology
  • Drug Interactions
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Estradiol / analogs & derivatives*
  • Estradiol / pharmacology*
  • Fulvestrant
  • Humans
  • Kinetics
  • Lignans*
  • Masoprocol / pharmacology
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Potassium Channel Blockers / pharmacology*
  • Potassium Channels, Calcium-Activated / antagonists & inhibitors*
  • Receptors, Estrogen / antagonists & inhibitors*

Substances

  • Biphenyl Compounds
  • Lignans
  • Potassium Channel Blockers
  • Potassium Channels, Calcium-Activated
  • Receptors, Estrogen
  • magnolol
  • Fulvestrant
  • Estradiol
  • 2-Methoxyestradiol
  • Masoprocol